Prescription Access Litigation's parent organization, Community Catalyst, has launched a new program in conjunction with the Alosa Foundation called Generics are Powerful Medicine. Generics are Powerful Medicine (GPM) is a national project to educate con

Reading the fine print Glad we read the Boston Globe this week, where we stumbled across this great opinion piece by internal medicine resident Dr. Michael Hochman, who says that recent revelations about pharmaceutical companies ability to bury unfavorabl

When we heard this 'Marketplace' story about the economics of a box-office flop, we couldn’t help but think it all sounded a bit familiar.  Referring to the current kids film Speedracer, 'Marketplace' anchor Kai Ryssdal reported that, “Warner Bros. put $1

We've often gotten on the soapbox here at the Prescription Access Litigation blog to preach against the evils of preemption. Preemption is the constitutional doctrine that when state law and federal law are in conflict, the federal law trumps or "preemp

Readers: It's a week of all-star guest blog posts here at the Prescription Access Litigation blog, and we're going overseas. Earlier this week, we brought you Sarah Rimmington of the consumer advocacy group, Essential Action, with a post on "the WHO’s ne

So long, samples The Carolinas HealthCare System is nearly halfway through its first year of zero free drug samples, reports the Charlotte Observer.  Dr. William Sugg, the medical director of the 600-member CHS physician network, told the Observer that th

We first read about Congressman Steve Kagen’s insurance status on the Wall Street Journal Health Blog, which pointed to this article in the Scientific American. Apparently, Rep. Kagen, a Wisconsin physician who joined the U.S. House of Representatives las

Dearest Readers: From time to time, it is our pleasure to bring you posts here on the Prescription Access Litigation blog written by guest bloggers. Our latest guest blog entry is by Sarah Rimmington of the consumer advocacy group Essential Action. It'

Recently, we posted an entry here titled "What is Abbott trying to hide? Maker of Norvir asks Court to deny public the right to see documents." We're pleased to report that the Court denied Abbott's motion to keep some documents under seal. We analyze th